Pfizer exec sees ‘significant opportunity’ to increase COVID vaccine price for annual booster shot

DM

A top Pfizer executive told shareholders the company is looking at a “significant opportunity” to raise the price of its Pfizer-BioNTech COVID-19 vaccine. While addressing investors at the virtual Barclays Global Healthcare Conference last week, Pfizer CFO Frank D’Amelio noted they could raise prices when the virus becomes endemic, meaning it’s regularly found in clusters around the globe, according to a transcript of the conference posted on Pfizer’s website.

Notifications - Subscriptions
Notify of
8 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

8
0
Would love your thoughts, please comment.x
()
x